New structure–activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity

References

• Allikmets R Schriml LM Hutchinson A Romano-Spica V Dean M A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res 1998 58 23 5337 5339 9850061
   PubMed Web of Science ®Google Scholar
• Doyle LA Yang W Abruzzo LV A multidrug resistance transporter from human MCF-7 breast cancer cells Proc Natl Acad Sci U S A 1998 95 26 15665 15670 9861027
   PubMed Web of Science ®Google Scholar
• Miyake K Mickley L Litman T Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Res 1999 59 1 8 13 9892175
   PubMed Web of Science ®Google Scholar
• Endicott JA Ling V The biochemistry of P-glycoprotein-mediated multidrug resistance Annu Rev Biochem 1989 58 137 171 2570548
   PubMed Web of Science ®Google Scholar
• Cole SPC Bhardwaj G Gerlach JH Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 1992 258 5088 1650 1654 1360704
   PubMed Web of Science ®Google Scholar
• Steinbach D Sell W Voigt A Hermann J Zintl F Sauerbray A BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia Leukemia 2002 16 8 1443 1447 12145683
   PubMed Web of Science ®Google Scholar
• Ho MM Hogge DE Ling V MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia Exp Hematol 2008 36 4 433 442 18249061
   PubMed Web of Science ®Google Scholar
• Seamon JA Rugg CA Emanuel S Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor Mol Cancer Ther 2006 5 10 2459 2467 17041089
   PubMed Web of Science ®Google Scholar
• Breedveld P Beijnen JH Schellens JHM Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs Trends Pharmacol Sci 2006 27 1 17 24 16337012
   PubMed Web of Science ®Google Scholar
• Ahmed-Belkacem A Pozza A Macalou S Perez-Victoria JM Boumendjel A Di Pietro A Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2) Anticancer Drugs 2006 17 3 239 244 16520651
   PubMed Web of Science ®Google Scholar
• Boumendjel A Macalou S Valdameri G Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation Curr Med Chem 2011 18 22 3387 3401 21728961
   PubMed Web of Science ®Google Scholar
• de Bruin M Miyake K Litman T Robey RW Bates SE Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR Cancer Lett 1999 146 2 117 126 10656616
   PubMed Web of Science ®Google Scholar
• Robey RW Steadman K Polgar O Pheophorbide a is a specific probe for ABCG2 function and inhibition Cancer Res 2004 64 4 1242 1246 14973080
   PubMed Web of Science ®Google Scholar
• Rabindran SK He H Singh M Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C Cancer Res 1998 58 24 5850 5858 9865745
   PubMed Web of Science ®Google Scholar
• Allen JD van Loevezijn A Lakhai JM Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C Mol Cancer Ther 2002 1 6 417 425 12477054
   PubMed Web of Science ®Google Scholar
• Kühnle M Egger M Muller C Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the P-glycoprotein (ABCB1) modulator tariquidar J Med Chem 2009 52 4 1190 1197 19170519
   PubMed Web of Science ®Google Scholar
• Boumendjel A Macalou S Ahmed-Belkacem A Blanc M Di Pietro A Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2 Bioorg Med Chem 2007 15 8 2892 2897 17317193
   PubMed Web of Science ®Google Scholar
• Arnaud O Boumendjel A Gèze A The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan Eur J Cancer 2011 47 4 640 648 21216589
   PubMed Web of Science ®Google Scholar
• Zhang S Yang X Morris ME Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport Mol Pharmacol 2004 65 5 1208 1216 15102949
   PubMed Web of Science ®Google Scholar
• Zhang S Yang X Coburn RA Morris ME Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein Biochem Pharmacol 2005 70 4 627 639 15979586
   PubMed Web of Science ®Google Scholar
• Ahmed-Belkacem A Pozza A Munoz-Martinez F Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2 Cancer Res 2005 65 11 4852 4860 15930306
   PubMed Web of Science ®Google Scholar
• Valdameri G Pereira Rangel L Sapatafora C Methoxy stilbenes as potent, specific, untransported and noncytotoxic inhibitors of breast cancer resistance protein ACS Chem Biol 2012 7 2 322 330 22039929
   PubMed Web of Science ®Google Scholar
• Macalou S Ahmed-Belkacem A Borelli F Non-prenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors J Med Chem 2007 50 8 1933 1938 17341062
   PubMed Web of Science ®Google Scholar
• Valdameri G Genoux-Bastide E Peres B Substituted chromones as highly-potent, nontoxic inhibitors, specific for the breast cancer resistance protein ABCG2 J Med Chem 2012 55 2 966 970 22165858
   PubMed Web of Science ®Google Scholar
• Nicolle E Boccard J Guilet D Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation-energy approach Eur J Pharm Sci 2009 38 1 39 46 19501160
   PubMed Web of Science ®Google Scholar
• Nicolle E Boumendjel A Macalou S QSAR analysis and molecular modeling of ABCG2-specific inhibitors Adv Drug Deliver Rev 2009 61 1 34 46
   Web of Science ®Google Scholar
• Han Y Riwanto M Go ML Ee PLR Modulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analogues Eur J Pharm Sci 2008 35 1–2 30 41 18598762
   PubMed Web of Science ®Google Scholar
• Juvale K Pape VFS Wiese M Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein Bioorg Med Chem 2012 20 1 346 355 22112540
   PubMed Web of Science ®Google Scholar
• Valdameri G Gauthier C Terreux R Investigation of chalcones as selective inhibitors of the breast cancer resistance protein ABCG2: critical role of methoxy substituents in both inhibition and cytotoxicity J Med Chem 2012 55 7 3193 3200 22449016
   PubMed Web of Science ®Google Scholar
• Chiaradia LD dos Santos R Vítor CE Synthesis and pharmacological activity of chalcones derived from 2,4,6-trimethoxyacetophenone in RAW 264.7 cells stimulated by LPS: quantitative structure-activity relationships Bioorg Med Chem 2008 16 2 658 667 17988874
   PubMed Web of Science ®Google Scholar
• Gulati KC Seth SR Venkataraman K Phloracetophenone Organic Synth 1943 2 522
   Google Scholar
• Boeck P Bandeira Falcão CAB Leal PC Synthesis of chalcone analogues with increased antileishmanial activity Bioorg Med Chem 2006 14 5 1538 1545 16386424
   PubMed Web of Science ®Google Scholar
• Cechinel-Filho V Vaz ZR Zunino L Calixto JB Yunes RA Synthesis of xanthoxyline derivatives with antinociceptive and antioedematogenic activities Eur J Med Chem 1996 31 10 833 839
   Web of Science ®Google Scholar
• Tsai S Klinman JP De Novo design and utilization of photolabile caged substrates as probes of hydrogen tunneling with horse liver alcohol dehydrogenase at sub-zero temperatures: a cautionary note Bioorg Chem 2003 31 2 172 190 12729574
   PubMed Web of Science ®Google Scholar
• Insuasty B Orozco F Quiroga J Abonia R Nogueras M Cobo J Microwave induced synthesis of novel 8,9-dihydro-7H-pyrimido[4,5-b] [1,4]diazepines as potential antitumor agents Eur J Med Chem 2008 43 9 1955 1962 18222571
   PubMed Web of Science ®Google Scholar
• Borchhardt DM Mascarello A Chiaradia LD Biochemical evaluation of a series of synthetic chalcone and hydrazide derivatives as novel inhibitors of cruzain from Trypanosoma cruzi J Braz Chem Soc 2010 21 1 142 150
   Web of Science ®Google Scholar
• Damazio RG Zanatta AP Cazarolli LH Nitrochalcones: Potential in vivo insulin secretagogues Biochimie 2009 91 11–12 1493 1598 19747522
   PubMed Web of Science ®Google Scholar
• Sadashivamurthy B Basavaraju YB New tetralone esters as intermediates for the synthesis of podophyllotoxin analogs Indian J Heterocycl Chem 2006 15 3 259 262
   Web of Science ®Google Scholar
• Sathisha AD Hemakumar KH Basavaraju YB Synthesis of new tetralone ester intermediates for podophyllotoxin analogues Indian J Heterocycl Chem 2007 17 1 15 18
   Web of Science ®Google Scholar
• Parmar VS Sharma S Rathore JS Carbon-13 nuclear magnetic resonance studies on 1,3-diphenylprop-2-enones Magn Reson Chem 1990 28 5 470 474
   Web of Science ®Google Scholar
• Wattanasin S Murthy WS An improved procedure for the preparation of chalcones and related enones Synthesis 1980 8 647 650
   Google Scholar
• Damazio RG Zanatta AP Cazarolli LH Antihyperglycemic activity of naphthylchalcones Eur J Med Chem 2010 45 4 1332 1337 20061067
   PubMed Web of Science ®Google Scholar
• Thirunarayanan G Effects of substituent on 1H and 13C NMR chemical shifts in substituted styryl 2-naphthyl ketones Acta Cienc Indica Chem 2003 29 3 147 150
   Google Scholar
• Winter E Chiaradia LD de Cordova CAS Nunes RJ Yunes RA Crezynski-Pasa TB Naphthylchalcones induce apoptosis and caspase activation in a leukemia cell line: The relationship between mitochondrial damage, oxidative stress, and cell death Bioorg Med Chem 2010 18 22 8026 8034 20952199
   PubMed Web of Science ®Google Scholar
• Robinson TP Hubbard RB Ehlers TJ Arbiser JL Goldsmith DJ Bowen JP Synthesis and biological evaluation of aromatic enones related to curcumin Bioorg Med Chem Lett 2005 13 12 4007 4013
   Web of Science ®Google Scholar
• Patel HS Patel VK Dixit BC Synthesis and antimicrobial activity of novel 2-amino-4-naphthyl-6-substituted phenylpyrimidine Orient J Chem 2001 17 3 142 150
   Google Scholar
• Chiaradia LD Martins PGA Cordeiro MNS Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB) J Med Chem 2012 55 1 390 402 22136336
   PubMed Web of Science ®Google Scholar
• Formento Navarini AL Chiaradia LD Mascarello A Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion Eur J Med Chem 2009 44 4 1630 1637 19211173
   PubMed Web of Science ®Google Scholar
• Chiaradia LD Mascarello A Purificaçao M Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA Bioorg Med Chem Lett 2008 18 23 6227 6230 18930396
   PubMed Web of Science ®Google Scholar
• Campos-Buzzi F Pereira de Campos J Tonini PP Antinociceptive effects of synthetic chalcones obtained from xanthoxyline Arch Pharm 2006 339 7 361 365
   Web of Science ®Google Scholar
• Mosmann T Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cyto-toxicity assays J Immunol Methods 1983 65 1–2 55 63 6606682
   PubMed Web of Science ®Google Scholar
• Telbisz A Hegedus C Ozvegy-Laczka C Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter Eur J Pharm Sci 2012 45 1–2 101 109 22115866
   PubMed Web of Science ®Google Scholar
• Sarkadi B Ozvegy-Laczka C Nemet K Varadi A ABCG2 – a transporter for all seasons FEBS Lett 2004 567 1 116 120 15165903
   PubMed Web of Science ®Google Scholar
• Ford JM Prozialeck WC Hait WN Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance Mol Pharmacol 1989 35 1 105 115 2563302
   PubMed Web of Science ®Google Scholar